[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649223":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":61,"collaborators":25,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":25,"enrollmentInfo":73,"targetDuration":25,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":89,"overallStatus":92,"whyStopped":25,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Clinique Bizet","OTHER",[8,14],{"label":9,"type":6,"description":10,"interventionNames":11},"standard 10-electrode ECG","Undergoes standard 10-electrode ECG acquisition first",[12,13],"Device: standard 10-electrode ECG acquisition","Device: 4-electrode DigitalCardio acquisition",{"label":15,"type":16,"description":17,"interventionNames":18},"4-electrode DigitalCardio","ACTIVE_COMPARATOR","Undergoes 4-electrode DigitalCardio",[12,13],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","standard 10-electrode ECG acquisition","Patient undergoes standard 10-electrode ECG acquisition. Then anonymized ECG traces is printed are submitted to independent evaluators. Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads. Followed immediately by 4-electrode DigitalCardio acquisition.",[15,9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"4-electrode DigitalCardio acquisition","Patient undergoes 4-electrode DigitalCardio acquisition acquisition. Then anonymized ECG traces is printed are submitted to independent evaluators. Evaluators independently assess trace quality based on standardized criteria, comparing automated measurements (frontal axis, median QRS duration, and QT interval) and counting any missing or erroneous leads. Followed immediately by standard 10-electrode ECG acquisition.",[15,9],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Bouchra BENKESSOU Chef de projet Recherche Clinique","CONTACT","+33 7 64 48 60 16","b.benkessou@hexagone-sante-paris.fr",[37,53],{"facility":38,"status":25,"city":39,"state":25,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Benkessou","Paris","75016","France","FR",{"type":44,"coordinates":45},"Point",[46,47],2.3488,48.85341,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":52,"phoneExt":25,"email":35},"benkessou BOUCHRA","0764486016",{"facility":54,"status":25,"city":39,"state":25,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"Bizet Clinic",{"type":44,"coordinates":56},[46,47],{"lat":47,"lon":46},[59],{"name":51,"role":33,"phone":52,"phoneExt":25,"email":60},"b.benkessou@cliniques-bltparis.fr",{"type":62,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100649223","4-electrode-ecg-digitalcardio-vs-standard-10-electrode-ecg-evaluating-ease-of-use-and-recording-quality-100649223",false,"NCT07732283","4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality","FAST-ECG","Inclusion Criteria:\n\nHospitalized Cardiology Patients:\n\n* Age minimum 18 years\n* Hospitalized for an acute or chronic cardiac condition (e.g., heart failure, acute coronary syndrome, arrhythmia, valvular heart disease, etc.)\n* Ability to give informed consent\n* Hemodynamic stability permitting the performance of an ECG without clinical risk\n\nCardiology Outpatients:\n\n* Age minimum of 18 years\n* Follow-up for a known cardiac condition or suspected cardiovascular disease\n* No contraindications to performing an ECG\n* Informed consent obtained\n\nExclusion Criteria:\n\n* Minor patient (\\\u003C 18 years of age)\n* Adult subject under legal protection, under temporary guardianship, curatorship, or tutelage\n* Patient refusing to participate in the study\n* Presence of an implantable cardiac device (e.g., pacemaker, defibrillator) that may interfere with ECG measurements\n* Severe skin condition preventing the placement of electrodes\n* Physical or cognitive inability to follow the study protocol\n* Current pregnancy",true,"ALL","18 Years",{"count":74,"type":75},50,"ESTIMATED","INTERVENTIONAL",[78],"NA","The goal of this clinical trial is to compare the time required to record a complete Electrocardiogram (ECG) trace using the DigitalCardio (CardioSecur®) tablet device versus a standard 12-lead ECG device in eligible patients.\n\nThe main questions it aims to answer are:\n\nIs there a difference in diagnostic recording time (in minutes) between the DigitalCardio tablet and a standard ECG machine? How do the two devices compare in terms of trace quality (including QRS duration, QT interval, frontal axis measurements, and missing\u002Ferroneous leads)? How satisfied are healthcare professionals with the CardioSecur® device?\n\nResearchers will compare Group A (standard 10-electrode ECG followed by 4-electrode ECG) to Group B (4-electrode ECG followed by standard 10-electrode ECG) in a 1:1 randomized crossover design to evaluate recording efficiency and trace quality.\n\nParticipants will:\n\nComplete an initial screening visit with the principal investigator to review eligibility criteria and sign the informed consent form.\n\nBe randomly assigned (1:1 ratio) to either Group A or Group B. Undergo both ECG recording methods sequentially (a standard 10-electrode ECG and a 4-electrode ECG using the DigitalCardio tablet), while researchers measure the total time elapsed from electrode placement to obtaining a complete trace.",[81,82,83,84,85,86,87,88],"4-electrode Tablet-based Electrocardiogram (ECG) System","Electrical Activity of the Heart","Atrial or Ventricular Arrhythmias","Intracardiac Conduction Abnormalities","QT Interval Prolongation","Myocardial Ischemia","Ventricular Hypertrophy","Tandard 12-lead (10-electrode) ECG Device",[90,91],"4-electrode tablet-based Electrocardiogram (ECG) system","standard 12-lead (10-electrode) ECG device","NOT_YET_RECRUITING","2026-07-28",{"date":95,"type":96},"2026-07-29","ACTUAL",{"date":98,"type":75},"2026-06",{"date":100,"type":75},"2027-03",{"name":5,"class":6},2]